# Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

> **NCT00315133** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 25 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **PROCEDURE:** Immunosuppression and autologous stem cell transplantation

## Key facts

- **NCT ID:** NCT00315133
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2010-12
- **Final completion:** 2014-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315133, "Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00315133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*